nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—glaucoma	0.665	1	CbGaD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.0021	0.0729	CbGpPWpGaD
Magnesium salicylate—Trisalicylate-choline—PTGS2—glaucoma	0.00179	0.314	CrCbGaD
Magnesium salicylate—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00167	0.0578	CbGpPWpGaD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00144	0.0497	CbGpPWpGaD
Magnesium salicylate—PTGS2—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00114	0.0395	CbGpPWpGaD
Magnesium salicylate—Salicylate-sodium—PTGS2—glaucoma	0.00108	0.19	CrCbGaD
Magnesium salicylate—Pain—Latanoprost—glaucoma	0.000768	0.00256	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Methazolamide—glaucoma	0.000765	0.00255	CcSEcCtD
Magnesium salicylate—Tinnitus—Brinzolamide—glaucoma	0.000759	0.00253	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS2—glaucoma	0.000759	0.133	CrCbGaD
Magnesium salicylate—Erythema—Brimonidine—glaucoma	0.000755	0.00252	CcSEcCtD
Magnesium salicylate—Olsalazine—PTGS2—glaucoma	0.000742	0.13	CrCbGaD
Magnesium salicylate—Dysgeusia—Brimonidine—glaucoma	0.00074	0.00247	CcSEcCtD
Magnesium salicylate—Urticaria—Methazolamide—glaucoma	0.000737	0.00246	CcSEcCtD
Magnesium salicylate—Dizziness—Metipranolol—glaucoma	0.000732	0.00244	CcSEcCtD
Magnesium salicylate—Tinnitus—Pilocarpine—glaucoma	0.00073	0.00243	CcSEcCtD
Magnesium salicylate—Flushing—Pilocarpine—glaucoma	0.000727	0.00242	CcSEcCtD
Magnesium salicylate—Erythema—Dorzolamide—glaucoma	0.000721	0.0024	CcSEcCtD
Magnesium salicylate—Erythema—Travoprost—glaucoma	0.000718	0.00239	CcSEcCtD
Magnesium salicylate—Oedema—Apraclonidine—glaucoma	0.000718	0.00239	CcSEcCtD
Magnesium salicylate—Pruritus—Diclofenamide—glaucoma	0.000713	0.00238	CcSEcCtD
Magnesium salicylate—Weight increased—Clonidine—glaucoma	0.000711	0.00237	CcSEcCtD
Magnesium salicylate—Erythema—Brinzolamide—glaucoma	0.000709	0.00236	CcSEcCtD
Magnesium salicylate—Dysgeusia—Dorzolamide—glaucoma	0.000706	0.00235	CcSEcCtD
Magnesium salicylate—Dysgeusia—Travoprost—glaucoma	0.000703	0.00234	CcSEcCtD
Magnesium salicylate—Rash—Metipranolol—glaucoma	0.000698	0.00233	CcSEcCtD
Magnesium salicylate—Dermatitis—Metipranolol—glaucoma	0.000697	0.00232	CcSEcCtD
Magnesium salicylate—Drowsiness—Clonidine—glaucoma	0.000696	0.00232	CcSEcCtD
Magnesium salicylate—Dysgeusia—Brinzolamide—glaucoma	0.000694	0.00231	CcSEcCtD
Magnesium salicylate—Headache—Metipranolol—glaucoma	0.000693	0.00231	CcSEcCtD
Magnesium salicylate—Pruritus—Levobunolol—glaucoma	0.000685	0.00228	CcSEcCtD
Magnesium salicylate—Asthma—Betaxolol—glaucoma	0.00068	0.00227	CcSEcCtD
Magnesium salicylate—Dizziness—Carteolol—glaucoma	0.000678	0.00226	CcSEcCtD
Magnesium salicylate—Diarrhoea—Carbachol—glaucoma	0.000673	0.00224	CcSEcCtD
Magnesium salicylate—Sweating—Clonidine—glaucoma	0.000668	0.00223	CcSEcCtD
Magnesium salicylate—Dysgeusia—Pilocarpine—glaucoma	0.000667	0.00222	CcSEcCtD
Magnesium salicylate—Dizziness—Diclofenamide—glaucoma	0.000666	0.00222	CcSEcCtD
Magnesium salicylate—Diarrhoea—Levobunolol—glaucoma	0.000663	0.00221	CcSEcCtD
Magnesium salicylate—ALB—HDL-mediated lipid transport—ABCA1—glaucoma	0.00066	0.0229	CbGpPWpGaD
Magnesium salicylate—Nausea—Metipranolol—glaucoma	0.000657	0.00219	CcSEcCtD
Magnesium salicylate—Epistaxis—Clonidine—glaucoma	0.000657	0.00219	CcSEcCtD
Magnesium salicylate—Dizziness—Carbachol—glaucoma	0.00065	0.00217	CcSEcCtD
Magnesium salicylate—Confusional state—Acetazolamide—glaucoma	0.000648	0.00216	CcSEcCtD
Magnesium salicylate—Headache—Carteolol—glaucoma	0.000642	0.00214	CcSEcCtD
Magnesium salicylate—Vomiting—Diclofenamide—glaucoma	0.000641	0.00214	CcSEcCtD
Magnesium salicylate—Dizziness—Levobunolol—glaucoma	0.00064	0.00213	CcSEcCtD
Magnesium salicylate—Somnolence—Apraclonidine—glaucoma	0.000638	0.00213	CcSEcCtD
Magnesium salicylate—Pruritus—Latanoprost—glaucoma	0.000635	0.00212	CcSEcCtD
Magnesium salicylate—Rash—Diclofenamide—glaucoma	0.000635	0.00212	CcSEcCtD
Magnesium salicylate—Diarrhoea—Methazolamide—glaucoma	0.000635	0.00212	CcSEcCtD
Magnesium salicylate—Shock—Acetazolamide—glaucoma	0.000632	0.00211	CcSEcCtD
Magnesium salicylate—Headache—Diclofenamide—glaucoma	0.000631	0.0021	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS2—glaucoma	0.000631	0.111	CrCbGaD
Magnesium salicylate—Vomiting—Carbachol—glaucoma	0.000625	0.00208	CcSEcCtD
Magnesium salicylate—Hepatitis—Clonidine—glaucoma	0.000625	0.00208	CcSEcCtD
Magnesium salicylate—Hallucination—Clonidine—glaucoma	0.000622	0.00207	CcSEcCtD
Magnesium salicylate—Rash—Carbachol—glaucoma	0.00062	0.00207	CcSEcCtD
Magnesium salicylate—Dermatitis—Carbachol—glaucoma	0.00062	0.00207	CcSEcCtD
Magnesium salicylate—Weight increased—Betaxolol—glaucoma	0.000619	0.00206	CcSEcCtD
Magnesium salicylate—Somnolence—Bimatoprost—glaucoma	0.000619	0.00206	CcSEcCtD
Magnesium salicylate—Oedema—Brimonidine—glaucoma	0.000616	0.00205	CcSEcCtD
Magnesium salicylate—Headache—Carbachol—glaucoma	0.000616	0.00205	CcSEcCtD
Magnesium salicylate—Pain—Apraclonidine—glaucoma	0.000614	0.00205	CcSEcCtD
Magnesium salicylate—Constipation—Apraclonidine—glaucoma	0.000614	0.00205	CcSEcCtD
Magnesium salicylate—Dyspepsia—Bimatoprost—glaucoma	0.000613	0.00204	CcSEcCtD
Magnesium salicylate—Nausea—Carteolol—glaucoma	0.000609	0.00203	CcSEcCtD
Magnesium salicylate—Headache—Levobunolol—glaucoma	0.000607	0.00202	CcSEcCtD
Magnesium salicylate—Shock—Brimonidine—glaucoma	0.000606	0.00202	CcSEcCtD
Magnesium salicylate—Nausea—Diclofenamide—glaucoma	0.000599	0.00199	CcSEcCtD
Magnesium salicylate—Pain—Bimatoprost—glaucoma	0.000595	0.00198	CcSEcCtD
Magnesium salicylate—Dizziness—Latanoprost—glaucoma	0.000594	0.00198	CcSEcCtD
Magnesium salicylate—Confusional state—Dorzolamide—glaucoma	0.000594	0.00198	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Apraclonidine—glaucoma	0.000592	0.00197	CcSEcCtD
Magnesium salicylate—Vomiting—Methazolamide—glaucoma	0.00059	0.00197	CcSEcCtD
Magnesium salicylate—Oedema—Dorzolamide—glaucoma	0.000589	0.00196	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Timolol—glaucoma	0.000587	0.00196	CcSEcCtD
Magnesium salicylate—Oedema—Travoprost—glaucoma	0.000586	0.00195	CcSEcCtD
Magnesium salicylate—Rash—Methazolamide—glaucoma	0.000585	0.00195	CcSEcCtD
Magnesium salicylate—Dermatitis—Methazolamide—glaucoma	0.000584	0.00195	CcSEcCtD
Magnesium salicylate—Nausea—Carbachol—glaucoma	0.000584	0.00195	CcSEcCtD
Magnesium salicylate—Tinnitus—Clonidine—glaucoma	0.000583	0.00194	CcSEcCtD
Magnesium salicylate—Sweating—Betaxolol—glaucoma	0.000581	0.00194	CcSEcCtD
Magnesium salicylate—Headache—Methazolamide—glaucoma	0.000581	0.00194	CcSEcCtD
Magnesium salicylate—Shock—Dorzolamide—glaucoma	0.000579	0.00193	CcSEcCtD
Magnesium salicylate—Hypotension—Brimonidine—glaucoma	0.000576	0.00192	CcSEcCtD
Magnesium salicylate—Nausea—Levobunolol—glaucoma	0.000575	0.00192	CcSEcCtD
Magnesium salicylate—Epistaxis—Betaxolol—glaucoma	0.000572	0.00191	CcSEcCtD
Magnesium salicylate—Somnolence—Acetazolamide—glaucoma	0.000571	0.0019	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Dorzolamide—glaucoma	0.000569	0.0019	CcSEcCtD
Magnesium salicylate—Rash—Latanoprost—glaucoma	0.000566	0.00189	CcSEcCtD
Magnesium salicylate—Dermatitis—Latanoprost—glaucoma	0.000566	0.00189	CcSEcCtD
Magnesium salicylate—Dyspepsia—Acetazolamide—glaucoma	0.000565	0.00188	CcSEcCtD
Magnesium salicylate—Headache—Latanoprost—glaucoma	0.000563	0.00188	CcSEcCtD
Magnesium salicylate—Anorexia—Dorzolamide—glaucoma	0.000561	0.00187	CcSEcCtD
Magnesium salicylate—Confusional state—Pilocarpine—glaucoma	0.000561	0.00187	CcSEcCtD
Magnesium salicylate—Decreased appetite—Acetazolamide—glaucoma	0.000558	0.00186	CcSEcCtD
Magnesium salicylate—Oedema—Pilocarpine—glaucoma	0.000556	0.00185	CcSEcCtD
Magnesium salicylate—Asthma—Timolol—glaucoma	0.000556	0.00185	CcSEcCtD
Magnesium salicylate—Nausea—Methazolamide—glaucoma	0.000551	0.00184	CcSEcCtD
Magnesium salicylate—Hypotension—Dorzolamide—glaucoma	0.00055	0.00183	CcSEcCtD
Magnesium salicylate—Somnolence—Brimonidine—glaucoma	0.000548	0.00183	CcSEcCtD
Magnesium salicylate—Hypotension—Travoprost—glaucoma	0.000548	0.00183	CcSEcCtD
Magnesium salicylate—Shock—Pilocarpine—glaucoma	0.000547	0.00182	CcSEcCtD
Magnesium salicylate—Erythema—Clonidine—glaucoma	0.000544	0.00181	CcSEcCtD
Magnesium salicylate—Dyspepsia—Brimonidine—glaucoma	0.000543	0.00181	CcSEcCtD
Magnesium salicylate—Hallucination—Betaxolol—glaucoma	0.000542	0.00181	CcSEcCtD
Magnesium salicylate—Hypotension—Brinzolamide—glaucoma	0.000541	0.0018	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Pilocarpine—glaucoma	0.000538	0.00179	CcSEcCtD
Magnesium salicylate—Anorexia—Pilocarpine—glaucoma	0.00053	0.00177	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Acetazolamide—glaucoma	0.000529	0.00176	CcSEcCtD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—FN1—glaucoma	0.000528	0.0183	CbGpPWpGaD
Magnesium salicylate—Pain—Brimonidine—glaucoma	0.000527	0.00176	CcSEcCtD
Magnesium salicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.000527	0.0182	CbGpPWpGaD
Magnesium salicylate—Somnolence—Dorzolamide—glaucoma	0.000523	0.00174	CcSEcCtD
Magnesium salicylate—Hypotension—Pilocarpine—glaucoma	0.00052	0.00173	CcSEcCtD
Magnesium salicylate—Dyspepsia—Dorzolamide—glaucoma	0.000518	0.00173	CcSEcCtD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CA1—glaucoma	0.000516	0.0179	CbGpPWpGaD
Magnesium salicylate—Dyspepsia—Travoprost—glaucoma	0.000516	0.00172	CcSEcCtD
Magnesium salicylate—Somnolence—Brinzolamide—glaucoma	0.000514	0.00171	CcSEcCtD
Magnesium salicylate—Decreased appetite—Dorzolamide—glaucoma	0.000512	0.00171	CcSEcCtD
Magnesium salicylate—Urticaria—Acetazolamide—glaucoma	0.00051	0.0017	CcSEcCtD
Magnesium salicylate—Dyspepsia—Brinzolamide—glaucoma	0.000509	0.0017	CcSEcCtD
Magnesium salicylate—Pruritus—Apraclonidine—glaucoma	0.000508	0.00169	CcSEcCtD
Magnesium salicylate—Tinnitus—Betaxolol—glaucoma	0.000508	0.00169	CcSEcCtD
Magnesium salicylate—Flushing—Betaxolol—glaucoma	0.000505	0.00168	CcSEcCtD
Magnesium salicylate—Pain—Dorzolamide—glaucoma	0.000503	0.00168	CcSEcCtD
Magnesium salicylate—Decreased appetite—Brinzolamide—glaucoma	0.000503	0.00168	CcSEcCtD
Magnesium salicylate—Constipation—Travoprost—glaucoma	0.000501	0.00167	CcSEcCtD
Magnesium salicylate—Pain—Travoprost—glaucoma	0.000501	0.00167	CcSEcCtD
Magnesium salicylate—Pain—Brinzolamide—glaucoma	0.000495	0.00165	CcSEcCtD
Magnesium salicylate—Somnolence—Pilocarpine—glaucoma	0.000494	0.00165	CcSEcCtD
Magnesium salicylate—Pruritus—Bimatoprost—glaucoma	0.000492	0.00164	CcSEcCtD
Magnesium salicylate—Diarrhoea—Apraclonidine—glaucoma	0.000491	0.00164	CcSEcCtD
Magnesium salicylate—Dyspepsia—Pilocarpine—glaucoma	0.00049	0.00163	CcSEcCtD
Magnesium salicylate—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.000489	0.0169	CbGpPWpGaD
Magnesium salicylate—Feeling abnormal—Dorzolamide—glaucoma	0.000485	0.00162	CcSEcCtD
Magnesium salicylate—Decreased appetite—Pilocarpine—glaucoma	0.000484	0.00161	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Travoprost—glaucoma	0.000483	0.00161	CcSEcCtD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000477	0.0165	CbGpPWpGaD
Magnesium salicylate—Feeling abnormal—Brinzolamide—glaucoma	0.000477	0.00159	CcSEcCtD
Magnesium salicylate—Pain—Pilocarpine—glaucoma	0.000476	0.00159	CcSEcCtD
Magnesium salicylate—Constipation—Pilocarpine—glaucoma	0.000476	0.00159	CcSEcCtD
Magnesium salicylate—Sweating—Timolol—glaucoma	0.000475	0.00158	CcSEcCtD
Magnesium salicylate—Dizziness—Apraclonidine—glaucoma	0.000475	0.00158	CcSEcCtD
Magnesium salicylate—Erythema—Betaxolol—glaucoma	0.000474	0.00158	CcSEcCtD
Magnesium salicylate—Urticaria—Dorzolamide—glaucoma	0.000468	0.00156	CcSEcCtD
Magnesium salicylate—Epistaxis—Timolol—glaucoma	0.000467	0.00156	CcSEcCtD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000466	0.0161	CbGpPWpGaD
Magnesium salicylate—Dysgeusia—Betaxolol—glaucoma	0.000464	0.00155	CcSEcCtD
Magnesium salicylate—Dizziness—Bimatoprost—glaucoma	0.00046	0.00153	CcSEcCtD
Magnesium salicylate—Urticaria—Brinzolamide—glaucoma	0.00046	0.00153	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Pilocarpine—glaucoma	0.000458	0.00153	CcSEcCtD
Magnesium salicylate—Vomiting—Apraclonidine—glaucoma	0.000456	0.00152	CcSEcCtD
Magnesium salicylate—Dermatitis—Apraclonidine—glaucoma	0.000452	0.00151	CcSEcCtD
Magnesium salicylate—Headache—Apraclonidine—glaucoma	0.00045	0.0015	CcSEcCtD
Magnesium salicylate—Confusional state—Clonidine—glaucoma	0.000448	0.00149	CcSEcCtD
Magnesium salicylate—Oedema—Clonidine—glaucoma	0.000444	0.00148	CcSEcCtD
Magnesium salicylate—Hallucination—Timolol—glaucoma	0.000442	0.00147	CcSEcCtD
Magnesium salicylate—Diarrhoea—Acetazolamide—glaucoma	0.000439	0.00146	CcSEcCtD
Magnesium salicylate—Rash—Bimatoprost—glaucoma	0.000439	0.00146	CcSEcCtD
Magnesium salicylate—Dermatitis—Bimatoprost—glaucoma	0.000439	0.00146	CcSEcCtD
Magnesium salicylate—Shock—Clonidine—glaucoma	0.000437	0.00146	CcSEcCtD
Magnesium salicylate—Pruritus—Brimonidine—glaucoma	0.000436	0.00145	CcSEcCtD
Magnesium salicylate—Headache—Bimatoprost—glaucoma	0.000436	0.00145	CcSEcCtD
Magnesium salicylate—ALB—HDL-mediated lipid transport—APOE—glaucoma	0.000434	0.015	CbGpPWpGaD
Magnesium salicylate—Hyperhidrosis—Clonidine—glaucoma	0.000429	0.00143	CcSEcCtD
Magnesium salicylate—Nausea—Apraclonidine—glaucoma	0.000426	0.00142	CcSEcCtD
Magnesium salicylate—Dizziness—Acetazolamide—glaucoma	0.000425	0.00142	CcSEcCtD
Magnesium salicylate—Anorexia—Clonidine—glaucoma	0.000423	0.00141	CcSEcCtD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.000419	0.0145	CbGpPWpGaD
Magnesium salicylate—Pruritus—Dorzolamide—glaucoma	0.000416	0.00139	CcSEcCtD
Magnesium salicylate—Hypotension—Clonidine—glaucoma	0.000415	0.00138	CcSEcCtD
Magnesium salicylate—Pruritus—Travoprost—glaucoma	0.000415	0.00138	CcSEcCtD
Magnesium salicylate—Tinnitus—Timolol—glaucoma	0.000415	0.00138	CcSEcCtD
Magnesium salicylate—Nausea—Bimatoprost—glaucoma	0.000413	0.00138	CcSEcCtD
Magnesium salicylate—Pruritus—Brinzolamide—glaucoma	0.000409	0.00136	CcSEcCtD
Magnesium salicylate—Vomiting—Acetazolamide—glaucoma	0.000408	0.00136	CcSEcCtD
Magnesium salicylate—Dizziness—Brimonidine—glaucoma	0.000408	0.00136	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—TXN—glaucoma	0.000404	0.014	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Dorzolamide—glaucoma	0.000403	0.00134	CcSEcCtD
Magnesium salicylate—Headache—Acetazolamide—glaucoma	0.000402	0.00134	CcSEcCtD
Magnesium salicylate—Diarrhoea—Travoprost—glaucoma	0.000401	0.00134	CcSEcCtD
Magnesium salicylate—Diarrhoea—Brinzolamide—glaucoma	0.000396	0.00132	CcSEcCtD
Magnesium salicylate—Somnolence—Clonidine—glaucoma	0.000395	0.00132	CcSEcCtD
Magnesium salicylate—Pruritus—Pilocarpine—glaucoma	0.000394	0.00131	CcSEcCtD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000392	0.0136	CbGpPWpGaD
Magnesium salicylate—Confusional state—Betaxolol—glaucoma	0.00039	0.0013	CcSEcCtD
Magnesium salicylate—Dizziness—Dorzolamide—glaucoma	0.000389	0.0013	CcSEcCtD
Magnesium salicylate—Rash—Brimonidine—glaucoma	0.000389	0.0013	CcSEcCtD
Magnesium salicylate—Dermatitis—Brimonidine—glaucoma	0.000388	0.00129	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS2—glaucoma	0.000388	0.0681	CrCbGaD
Magnesium salicylate—Dizziness—Travoprost—glaucoma	0.000388	0.00129	CcSEcCtD
Magnesium salicylate—Erythema—Timolol—glaucoma	0.000387	0.00129	CcSEcCtD
Magnesium salicylate—Oedema—Betaxolol—glaucoma	0.000387	0.00129	CcSEcCtD
Magnesium salicylate—Headache—Brimonidine—glaucoma	0.000386	0.00129	CcSEcCtD
Magnesium salicylate—Decreased appetite—Clonidine—glaucoma	0.000386	0.00129	CcSEcCtD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000383	0.0133	CbGpPWpGaD
Magnesium salicylate—Dizziness—Brinzolamide—glaucoma	0.000383	0.00128	CcSEcCtD
Magnesium salicylate—Nausea—Acetazolamide—glaucoma	0.000381	0.00127	CcSEcCtD
Magnesium salicylate—Diarrhoea—Pilocarpine—glaucoma	0.000381	0.00127	CcSEcCtD
Magnesium salicylate—Shock—Betaxolol—glaucoma	0.00038	0.00127	CcSEcCtD
Magnesium salicylate—Pain—Clonidine—glaucoma	0.00038	0.00127	CcSEcCtD
Magnesium salicylate—Constipation—Clonidine—glaucoma	0.00038	0.00127	CcSEcCtD
Magnesium salicylate—ALB—Lipoprotein metabolism—ABCA1—glaucoma	0.000379	0.0131	CbGpPWpGaD
Magnesium salicylate—Dysgeusia—Timolol—glaucoma	0.000379	0.00126	CcSEcCtD
Magnesium salicylate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000379	0.0131	CbGpPWpGaD
Magnesium salicylate—Vomiting—Dorzolamide—glaucoma	0.000374	0.00125	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Betaxolol—glaucoma	0.000374	0.00125	CcSEcCtD
Magnesium salicylate—Rash—Dorzolamide—glaucoma	0.000371	0.00124	CcSEcCtD
Magnesium salicylate—Dermatitis—Dorzolamide—glaucoma	0.000371	0.00124	CcSEcCtD
Magnesium salicylate—Rash—Travoprost—glaucoma	0.00037	0.00123	CcSEcCtD
Magnesium salicylate—Dermatitis—Travoprost—glaucoma	0.000369	0.00123	CcSEcCtD
Magnesium salicylate—Headache—Dorzolamide—glaucoma	0.000369	0.00123	CcSEcCtD
Magnesium salicylate—Anorexia—Betaxolol—glaucoma	0.000369	0.00123	CcSEcCtD
Magnesium salicylate—Vomiting—Brinzolamide—glaucoma	0.000368	0.00123	CcSEcCtD
Magnesium salicylate—Dizziness—Pilocarpine—glaucoma	0.000368	0.00123	CcSEcCtD
Magnesium salicylate—Headache—Travoprost—glaucoma	0.000367	0.00122	CcSEcCtD
Magnesium salicylate—Nausea—Brimonidine—glaucoma	0.000366	0.00122	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Clonidine—glaucoma	0.000366	0.00122	CcSEcCtD
Magnesium salicylate—Rash—Brinzolamide—glaucoma	0.000365	0.00122	CcSEcCtD
Magnesium salicylate—Dermatitis—Brinzolamide—glaucoma	0.000365	0.00122	CcSEcCtD
Magnesium salicylate—Headache—Brinzolamide—glaucoma	0.000363	0.00121	CcSEcCtD
Magnesium salicylate—Hypotension—Betaxolol—glaucoma	0.000361	0.0012	CcSEcCtD
Magnesium salicylate—Vomiting—Pilocarpine—glaucoma	0.000354	0.00118	CcSEcCtD
Magnesium salicylate—Urticaria—Clonidine—glaucoma	0.000353	0.00118	CcSEcCtD
Magnesium salicylate—Rash—Pilocarpine—glaucoma	0.000351	0.00117	CcSEcCtD
Magnesium salicylate—Dermatitis—Pilocarpine—glaucoma	0.00035	0.00117	CcSEcCtD
Magnesium salicylate—Nausea—Dorzolamide—glaucoma	0.00035	0.00117	CcSEcCtD
Magnesium salicylate—Headache—Pilocarpine—glaucoma	0.000348	0.00116	CcSEcCtD
Magnesium salicylate—Nausea—Travoprost—glaucoma	0.000348	0.00116	CcSEcCtD
Magnesium salicylate—Nausea—Brinzolamide—glaucoma	0.000344	0.00115	CcSEcCtD
Magnesium salicylate—Dyspepsia—Betaxolol—glaucoma	0.00034	0.00113	CcSEcCtD
Magnesium salicylate—Decreased appetite—Betaxolol—glaucoma	0.000336	0.00112	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000333	0.0115	CbGpPWpGaD
Magnesium salicylate—Constipation—Betaxolol—glaucoma	0.000331	0.0011	CcSEcCtD
Magnesium salicylate—Pain—Betaxolol—glaucoma	0.000331	0.0011	CcSEcCtD
Magnesium salicylate—Nausea—Pilocarpine—glaucoma	0.00033	0.0011	CcSEcCtD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000321	0.0111	CbGpPWpGaD
Magnesium salicylate—Feeling abnormal—Betaxolol—glaucoma	0.000319	0.00106	CcSEcCtD
Magnesium salicylate—Confusional state—Timolol—glaucoma	0.000319	0.00106	CcSEcCtD
Magnesium salicylate—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000318	0.011	CbGpPWpGaD
Magnesium salicylate—Oedema—Timolol—glaucoma	0.000316	0.00105	CcSEcCtD
Magnesium salicylate—Pruritus—Clonidine—glaucoma	0.000314	0.00105	CcSEcCtD
Magnesium salicylate—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000311	0.0108	CbGpPWpGaD
Magnesium salicylate—Shock—Timolol—glaucoma	0.000311	0.00104	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS2—glaucoma	0.000308	0.054	CrCbGaD
Magnesium salicylate—Urticaria—Betaxolol—glaucoma	0.000307	0.00102	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Timolol—glaucoma	0.000305	0.00102	CcSEcCtD
Magnesium salicylate—Diarrhoea—Clonidine—glaucoma	0.000304	0.00101	CcSEcCtD
Magnesium salicylate—Anorexia—Timolol—glaucoma	0.000301	0.001	CcSEcCtD
Magnesium salicylate—Hypotension—Timolol—glaucoma	0.000295	0.000984	CcSEcCtD
Magnesium salicylate—Dizziness—Clonidine—glaucoma	0.000294	0.000979	CcSEcCtD
Magnesium salicylate—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000285	0.00985	CbGpPWpGaD
Magnesium salicylate—Vomiting—Clonidine—glaucoma	0.000282	0.000941	CcSEcCtD
Magnesium salicylate—Somnolence—Timolol—glaucoma	0.000281	0.000936	CcSEcCtD
Magnesium salicylate—Rash—Clonidine—glaucoma	0.00028	0.000934	CcSEcCtD
Magnesium salicylate—Dermatitis—Clonidine—glaucoma	0.00028	0.000933	CcSEcCtD
Magnesium salicylate—Headache—Clonidine—glaucoma	0.000278	0.000928	CcSEcCtD
Magnesium salicylate—Dyspepsia—Timolol—glaucoma	0.000278	0.000927	CcSEcCtD
Magnesium salicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000275	0.00952	CbGpPWpGaD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000275	0.00952	CbGpPWpGaD
Magnesium salicylate—Decreased appetite—Timolol—glaucoma	0.000275	0.000915	CcSEcCtD
Magnesium salicylate—Pruritus—Betaxolol—glaucoma	0.000274	0.000912	CcSEcCtD
Magnesium salicylate—Pain—Timolol—glaucoma	0.00027	0.000901	CcSEcCtD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000266	0.00921	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Betaxolol—glaucoma	0.000265	0.000882	CcSEcCtD
Magnesium salicylate—Nausea—Clonidine—glaucoma	0.000264	0.000879	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Timolol—glaucoma	0.00026	0.000868	CcSEcCtD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TXN—glaucoma	0.000259	0.00898	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000259	0.00896	CbGpPWpGaD
Magnesium salicylate—Dizziness—Betaxolol—glaucoma	0.000256	0.000852	CcSEcCtD
Magnesium salicylate—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.000252	0.00872	CbGpPWpGaD
Magnesium salicylate—Urticaria—Timolol—glaucoma	0.000251	0.000837	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.00025	0.00864	CbGpPWpGaD
Magnesium salicylate—ALB—Lipoprotein metabolism—APOE—glaucoma	0.000249	0.00863	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	0.000248	0.00859	CbGpPWpGaD
Magnesium salicylate—Vomiting—Betaxolol—glaucoma	0.000246	0.00082	CcSEcCtD
Magnesium salicylate—Rash—Betaxolol—glaucoma	0.000244	0.000813	CcSEcCtD
Magnesium salicylate—Dermatitis—Betaxolol—glaucoma	0.000244	0.000812	CcSEcCtD
Magnesium salicylate—Headache—Betaxolol—glaucoma	0.000242	0.000808	CcSEcCtD
Magnesium salicylate—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.00024	0.0083	CbGpPWpGaD
Magnesium salicylate—Nausea—Betaxolol—glaucoma	0.00023	0.000766	CcSEcCtD
Magnesium salicylate—Pruritus—Timolol—glaucoma	0.000224	0.000745	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000222	0.0077	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	0.000221	0.00765	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Timolol—glaucoma	0.000216	0.000721	CcSEcCtD
Magnesium salicylate—Dizziness—Timolol—glaucoma	0.000209	0.000696	CcSEcCtD
Magnesium salicylate—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000206	0.00715	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000205	0.00711	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—TGFB2—glaucoma	0.000203	0.00704	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—ABCA1—glaucoma	0.000202	0.00699	CbGpPWpGaD
Magnesium salicylate—Vomiting—Timolol—glaucoma	0.000201	0.00067	CcSEcCtD
Magnesium salicylate—Rash—Timolol—glaucoma	0.000199	0.000664	CcSEcCtD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000199	0.00689	CbGpPWpGaD
Magnesium salicylate—Dermatitis—Timolol—glaucoma	0.000199	0.000663	CcSEcCtD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000198	0.00686	CbGpPWpGaD
Magnesium salicylate—Headache—Timolol—glaucoma	0.000198	0.00066	CcSEcCtD
Magnesium salicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	0.000194	0.00673	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000194	0.00671	CbGpPWpGaD
Magnesium salicylate—Nausea—Timolol—glaucoma	0.000188	0.000626	CcSEcCtD
Magnesium salicylate—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000183	0.00634	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—SOD1—glaucoma	0.00018	0.00623	CbGpPWpGaD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000177	0.00612	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000177	0.00611	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000176	0.00611	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	0.000175	0.00607	CbGpPWpGaD
Magnesium salicylate—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	0.000166	0.00574	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000164	0.00569	CbGpPWpGaD
Magnesium salicylate—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.000164	0.00568	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—APOE—glaucoma	0.000163	0.00565	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	0.00016	0.00555	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—SOD1—glaucoma	0.000154	0.00534	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.000151	0.00522	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	0.00015	0.00518	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000147	0.00509	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP1B1—glaucoma	0.000146	0.00506	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—SOD1—glaucoma	0.000143	0.00495	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—MTHFR—glaucoma	0.000143	0.00494	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000142	0.00492	CbGpPWpGaD
Magnesium salicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000141	0.00489	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.00014	0.00485	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000136	0.00472	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000133	0.0046	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—BDNF—glaucoma	0.000131	0.00454	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000131	0.00453	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CA5A—glaucoma	0.000128	0.00445	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NARFL—glaucoma	0.000128	0.00445	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL1A—glaucoma	0.000126	0.00436	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000118	0.00409	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—GSTM1—glaucoma	0.000117	0.00404	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	0.000113	0.00392	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	0.000112	0.00389	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000111	0.00385	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000108	0.00375	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—FN1—glaucoma	0.000107	0.00372	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.000102	0.00354	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CA5A—glaucoma	0.000102	0.00353	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NARFL—glaucoma	0.000102	0.00353	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000101	0.00351	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000101	0.0035	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	9.91e-05	0.00343	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	9.75e-05	0.00338	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	9.72e-05	0.00337	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	9.47e-05	0.00328	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—LRP12—glaucoma	9.22e-05	0.00319	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	9.02e-05	0.00312	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	8.98e-05	0.00311	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	8.92e-05	0.00309	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	8.78e-05	0.00304	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.76e-05	0.00303	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA5A—glaucoma	8.25e-05	0.00286	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NARFL—glaucoma	8.25e-05	0.00286	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	7.64e-05	0.00264	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	7.59e-05	0.00263	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—TNF—glaucoma	7.54e-05	0.00261	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	7.22e-05	0.0025	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	6.84e-05	0.00237	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.75e-05	0.00234	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	6.69e-05	0.00232	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.53e-05	0.00226	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CA1—glaucoma	6.27e-05	0.00217	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MMP9—glaucoma	6.19e-05	0.00214	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—VEGFA—glaucoma	6.14e-05	0.00213	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TNF—glaucoma	6.14e-05	0.00213	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CTSA—glaucoma	6.07e-05	0.0021	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	6.03e-05	0.00209	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGFR1OP—glaucoma	5.94e-05	0.00206	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HEYL—glaucoma	5.94e-05	0.00206	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	5.85e-05	0.00203	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CA2—glaucoma	5.74e-05	0.00199	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.61e-05	0.00194	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.61e-05	0.00194	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TP53—glaucoma	5.41e-05	0.00187	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CA1—glaucoma	4.98e-05	0.00172	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.94e-05	0.00171	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TNF—glaucoma	4.88e-05	0.00169	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CTSA—glaucoma	4.82e-05	0.00167	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TNF—glaucoma	4.77e-05	0.00165	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	4.76e-05	0.00165	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TGFB2—glaucoma	4.65e-05	0.00161	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CA2—glaucoma	4.55e-05	0.00158	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.55e-05	0.00158	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.45e-05	0.00154	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.45e-05	0.00154	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—glaucoma	4.2e-05	0.00146	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TXN—glaucoma	4.04e-05	0.0014	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA1—glaucoma	4.03e-05	0.00139	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CTSA—glaucoma	3.9e-05	0.00135	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.78e-05	0.00131	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HDAC9—glaucoma	3.71e-05	0.00128	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.69e-05	0.00128	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA2—glaucoma	3.68e-05	0.00128	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.65e-05	0.00127	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.6e-05	0.00125	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.6e-05	0.00125	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SOD1—glaucoma	3.52e-05	0.00122	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.24e-05	0.00112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TXN—glaucoma	3.21e-05	0.00111	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTT1—glaucoma	3.13e-05	0.00108	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.93e-05	0.00101	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.9e-05	0.001	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.86e-05	0.00099	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	2.72e-05	0.000943	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MMP1—glaucoma	2.69e-05	0.000931	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TXN—glaucoma	2.6e-05	0.000899	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CAV1—glaucoma	2.58e-05	0.000892	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.53e-05	0.000875	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP1B1—glaucoma	2.5e-05	0.000864	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ABCA1—glaucoma	2.5e-05	0.000864	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTT1—glaucoma	2.49e-05	0.000861	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—FN1—glaucoma	2.45e-05	0.000849	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.37e-05	0.00082	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.35e-05	0.000812	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTT1—glaucoma	2.01e-05	0.000697	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTM1—glaucoma	2e-05	0.000691	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN2B—glaucoma	1.99e-05	0.000691	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ABCA1—glaucoma	1.98e-05	0.000686	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP1B1—glaucoma	1.98e-05	0.000686	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NOS3—glaucoma	1.95e-05	0.000675	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—MTHFR—glaucoma	1.76e-05	0.000611	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTHFR—glaucoma	1.67e-05	0.000579	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—APOE—glaucoma	1.64e-05	0.000569	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CAV1—glaucoma	1.63e-05	0.000563	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.62e-05	0.000562	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCA1—glaucoma	1.6e-05	0.000555	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP1B1—glaucoma	1.6e-05	0.000555	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTM1—glaucoma	1.58e-05	0.000549	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APOE—glaucoma	1.56e-05	0.000539	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CAV1—glaucoma	1.54e-05	0.000534	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BAD—glaucoma	1.45e-05	0.000502	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—glaucoma	1.4e-05	0.000486	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MTHFR—glaucoma	1.4e-05	0.000485	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—APOE—glaucoma	1.3e-05	0.000451	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CAV1—glaucoma	1.29e-05	0.000447	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTM1—glaucoma	1.28e-05	0.000444	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NOS3—glaucoma	1.23e-05	0.000426	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOS3—glaucoma	1.17e-05	0.000404	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MTHFR—glaucoma	1.13e-05	0.000392	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTGS2—glaucoma	1.13e-05	0.00039	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—glaucoma	1.06e-05	0.000367	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—APOE—glaucoma	1.05e-05	0.000365	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CAV1—glaucoma	1.04e-05	0.000362	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1B—glaucoma	1.01e-05	0.00035	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NOS3—glaucoma	9.77e-06	0.000338	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NOS3—glaucoma	7.9e-06	0.000274	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS2—glaucoma	7.23e-06	0.00025	CbGpPWpGaD
